Approval Sought For World’s 1st Malaria Vaccine

Approval sought for world’s 1st malaria vaccine

GlaxoSmithKline is seeking regulatory approval for the world’s first vaccine against malaria, after promising trial data showed that it cut cases of the often-fatal disease in African children.

The company has been developing the vaccine for 3 decades and plans to submit a regulatory application to the European Medicines Agency.

Malaria kills hundreds of thousands of people every year.

Photo: Malaria infected mosquitoes (AFP)